PHARMACOGENETIC DIRECTED DOSING LEADS TO OPTIMIZED VORICONAZOLE LEVELS IN PEDIATRIC PATIENTS RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANTS

被引：0
|
作者：
Teusink, Ashley
Vinks, Alexander
Zhang, Kejian
Davies, Stella
Filipovich, Alexandra
Fukuda, Tsuyoshi
Mehta, Parinda
机构：
[1] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA
[2] Cincinnati Childrens Hosp, CIBMTR, Cincinnati, OH USA
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [1] Pharmacogenetic Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplants
    Teusink, Ashley
    Vinks, Alexander
    Zhang, Kejian
    Fukuda, Tsuyoshi
    Davies, Stella M.
    Lane, Adam
    Filipovich, Alexandra
    Mehta, Parinda A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S99 - S100
  • [2] Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation
    Teusink, Ashley
    Vinks, Alexander
    Zhang, Kejian
    Davies, Stella
    Fukuda, Tsuyoshi
    Lane, Adam
    Nortman, Shannon
    Kissell, Diane
    Dell, Sarah
    Filipovich, Alexandra
    Mehta, Parinda
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : 482 - 486
  • [3] TACROLIMUS DOSING IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION RECIPIENTS RECEIVING VORICONAZOLE
    Trifilio, S. M.
    Pi, J.
    Singhal, S.
    Frankfurt, O.
    Evens, A.
    Gordon, L.
    Tallman, M.
    Williams, S.
    Mehta, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 115 - 116
  • [4] Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing
    Patel, Jai N.
    Robinson, Myra
    Morris, Sarah A.
    Jandrisevits, Elizabeth
    Lopes, Karine Eboli
    Hamilton, Alicia
    Steuerwald, Nury
    Druhan, Lawrence J.
    Avalos, Belinda
    Copelan, Edward
    Ghosh, Nilanjan
    Grunwald, Michael R.
    PHARMACOGENOMICS JOURNAL, 2023, 23 (6): : 201 - 209
  • [5] Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing
    Jai N. Patel
    Myra Robinson
    Sarah A. Morris
    Elizabeth Jandrisevits
    Karine Eboli Lopes
    Alicia Hamilton
    Nury Steuerwald
    Lawrence J. Druhan
    Belinda Avalos
    Edward Copelan
    Nilanjan Ghosh
    Michael R. Grunwald
    The Pharmacogenomics Journal, 2023, 23 : 201 - 209
  • [6] Disposition of two oral formulations of cyclosporine in pediatric patients receiving hematopoietic stem cell transplants
    Dupuis, LL
    Taylor, T
    Saunders, EF
    PHARMACOTHERAPY, 2006, 26 (01): : 15 - 22
  • [7] Elevated Fluoride Levels and Periostitis in Pediatric Hematopoietic Stem Cell Transplant Recipients Receiving Long-Term Voriconazole
    Tarlock, Katherine
    Johnson, Darren
    Cornell, Cathy
    Parnell, Shawn
    Meshinchi, Soheil
    Baker, K. Scott
    Englund, Janet A.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (05) : 918 - 920
  • [8] Tacrolimus dosing in allogeneic hematopoietic stem cell transplant (HSCT) recipients receiving concomitant voriconazole.
    Trifilio, Steven
    Pi, Judy
    Singhal, Seema
    Frankfurt, Olga
    Evens, Andrew
    Gordon, Leo
    Tallman, Martin
    Winter, Jane
    Williams, Stephanie
    Mehta, Jayesh
    BLOOD, 2007, 110 (11) : 315B - 315B
  • [9] EXPLORATORY PHARMACOGENETIC STUDY IN HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) RECIPIENTS RECEIVING CYP2C19-GUIDED VORICONAZOLE (VCZ) DOSING.
    Patel, J.
    Robinson, M.
    Jandrisevits, E.
    Eboli-Lopes, K.
    Morris, S.
    Hamilton, A.
    Smith, M.
    Steuerwald, N.
    Avalos, B.
    Copelan, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S40 - S40
  • [10] Monitoring plasma voriconazole levels may prevent subtheraputic dosing in pediatric stem cell transplant (SCT) patients
    Morris, J. D.
    Voskoboynik, D.
    Brown, W. C.
    Czarnecki, S.
    Morris, C. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345